Healthcare provider profile · identity verified

Robert Scott Feaster, M.D.

Emergency Medicine · COLLEGE STATION, TX · NPI 1891951018

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	293	45
Atorvastatin Calcium	Atorvastatin Calcium	270	85
Levothyroxine Sodium	Levothyroxine Sodium	229	64
Losartan Potassium	Losartan Potassium	227	71
Gabapentin	Gabapentin	189	50
Amlodipine Besylate	Amlodipine Besylate	180	59
Pravastatin Sodium	Pravastatin Sodium	170	46
Pantoprazole Sodium	Pantoprazole Sodium	164	50
Metformin Hcl	Metformin Hcl	154	48
Furosemide	Furosemide	152	56
Lisinopril	Lisinopril	152	48
Montelukast Sodium	Montelukast Sodium	150	40
Tizanidine Hcl	Tizanidine Hcl	140	52
Omeprazole	Omeprazole	122	34
Zolpidem Tartrate	Zolpidem Tartrate	122	20
Celecoxib	Celecoxib	109	35
Albuterol Sulfate Hfa	Albuterol Sulfate	108	35
Hydrochlorothiazide	Hydrochlorothiazide	102	28
Metoprolol Succinate	Metoprolol Succinate	86	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	26
Diclofenac Sodium	Diclofenac Sodium	82	34
Rosuvastatin Calcium	Rosuvastatin Calcium	82	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	29
Simvastatin	Simvastatin	76	21
Trazodone Hcl	Trazodone Hcl	71	27
Ondansetron Odt	Ondansetron	70	17
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Pregabalin	Pregabalin	68	11
Tramadol Hcl	Tramadol Hcl	67	20
Januvia	Sitagliptin Phosphate	66	15
Carvedilol	Carvedilol	65	24
Tamsulosin Hcl	Tamsulosin Hcl	65	24
Prednisone	Prednisone	64	45
Bupropion Xl	Bupropion Hcl	60	19
Famotidine	Famotidine	60	20
Eliquis	Apixaban	59	11
Potassium Chloride	Potassium Chloride	57	23
Duloxetine Hcl	Duloxetine Hcl	55	19
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Ozempic	Semaglutide	51	11
Meloxicam	Meloxicam	50	13
Metformin Hcl Er	Metformin Hcl	50	19
Clonazepam	Clonazepam	49	11
Pioglitazone Hcl	Pioglitazone Hcl	49	15
Alendronate Sodium	Alendronate Sodium	48	14
Finasteride	Finasteride	47	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	12
Fluoxetine Hcl	Fluoxetine Hcl	43	14
Sertraline Hcl	Sertraline Hcl	43	14
Naproxen	Naproxen	40	12
Doxycycline Hyclate	Doxycycline Hyclate	39	33
Allopurinol	Allopurinol	36	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	14
Synthroid	Levothyroxine Sodium	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	21
Acetaminophen-Codeine	Acetaminophen With Codeine	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	27	suppressed
Promethazine Hcl	Promethazine Hcl	27	suppressed
Estradiol	Estradiol	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Topiramate	Topiramate	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Fluconazole	Fluconazole	23	suppressed
Glipizide	Glipizide	23	suppressed
Baclofen	Baclofen	22	suppressed
Diazepam	Diazepam	22	suppressed
Jardiance	Empagliflozin	22	suppressed
Cefdinir	Cefdinir	21	17
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	16
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	13
Donepezil Hcl	Donepezil Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Temazepam	Temazepam	16	suppressed
Atenolol	Atenolol	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	12
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error